Sanaria Inc. and the Government of Equatorial Guinea last week signed an agreement that continues their joint ...
Concerto HealthAI has announced that they have entered into a collaboration with Pfizer to advance work in Precision Onc...
The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety ...
Myriad Genetics, a leader in personalized medicine has announced that it has expanded its companion diagnostic collabora...
Congresswoman Debbie Dingell was recognized by the Biotechnology Innovation Organization (BIO) for her leadership a...
In collaboration with Helix, PerkinElmer, Inc., a global leader committed to innovating for a healthier world has launch...
AIVITA Biomedical, Inc., a biotechnology company specializing in innovative stem cell applications has entered into a pa...
Johnson & Johnson announced that its subsidiary Ethicon has completed the acquisition of Auris Health for approximat...
Axcella Health, a biotechnology company pioneering the research and development of novel multifactorial interventions to...
Flexion Therapeutics has announced that Kerry Wentworth, Chief Regulatory Officer, has been appointed to the Massachuset...
Leaps by Bayer, the investment arm of the global life sciences company Bayer, and Khloris Biosciences, a biotechnology c...
ADMA Biologics, a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manu...
The European Society for Medical Oncology (ESMO) announced that Prof. Jonas Bergh from the Karolinska Institutet in Stoc...
Thermo Fisher Scientific announces the expansion of its portfolio of analytical instruments for clinical diagnostic labo...
The U.S. Food and Drug Administration (FDA) has announced important new steps to modernize breast cancer screening and h...
Celgene Corporation has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human ...
Boehringer Ingelheim has announced that it has acquired ICD Therapeutics. The acquisition includes rights to ICD&rs...
Cambridge Innovation Capital plc (CIC), the venture capital investor focused on intellectual property rich technology an...
